Advances in the treatment of chronic atrophic gastritis with a combination of Chinese and Western medicine and the public health implications

Abstract

Chronic atrophic gastritis (CAG) is a disease characterized by atrophy of the gastric mucosa and reduction of intrinsic glands, accompanied by intestinal hyperplasia and/or pseudopyloric glandular hyperplasia, and is a common clinical gastrointestinal lesion that can be produced by the interaction of multiple factors. The pathogenesis of CAG has not been completely clarified, and there are no specific drugs or treatment methods, and the disease is prone to recurrence. The pathogenesis of CAG is not fully understood, and there is no specific drug or treatment, and the disease is prone to recurrence. This paper reviews the treatment progress and public health implications of Western medicine, Chinese medicine, and the combination of Western and Chinese medicine in the treatment of chronic atrophic gastritis, in order to provide some reference for the clinical treatment and public prevention of chronic atrophic gastritis.